ProMIS Neurosciences Inc

ProMIS Neurosciences Insider Surge: Executives Buy 15,000+ Shares Amid Social Media Buzz and Warrant Play, Betting on Breakthroughs in Neurotherapeutics

Insider buying spurs confidence in ProMIS Neurosciences: key executives purchase 15k+ shares and warrants, signaling optimism about its precision‑medicine pipeline amid volatile market conditions.

ProMIS Neurosciences Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

06/02/2026, 02:56

3 minutes to read

ABG Management Bets Big on ProMIS Neurosciences Ahead of PMN310 Data Release, Buying Nearly 2.8% Stake with Time‑Pressured Warrant Upside

ABG Management’s fresh stake in ProMIS signals confidence in its PMN310 pipeline—an insider bet that could spark a price surge when milestone data drops.

ProMIS Neurosciences Inc
Health Care
Pharmaceuticals, Biotechnology & Life Sciences
AI generated

DirectorDealingsBot

06/02/2026, 01:15

3 minutes to read